Navigation Links
New partnership brings more personalized cancer treatment to Philadelphia
Date:7/23/2014

(PHILADELPHIA) The Worldwide Innovative Networking in personalized cancer medicine, (the WIN consortium), recently announced that the Sidney Kimmel Cancer Center at Thomas Jefferson University will be one of its six new members the only member of this prestigious group in the Tri-State Area. The goal of WIN is to speed the delivery of innovative personalized medicine to the patient by forging collaborations between partners in academia, industry, and patient advocacy.

"Our participation in the WIN consortium means Jefferson cancer patients will have access to worldwide clinical trials on promising and individualized therapies," says Massimo Cristofanilli, M.D., Director of the Jefferson Breast Care Center. "It creates a global oncology, a technologically advanced approach to managing our patients."

The consortium was formed in 2010 and today is made up of 24 member cancer centers across 16 countries and four continents. It includes four major technology partners, three pharmaceutical companies and five non-profit or patient advocacy groups. The goal of the network is to facilitate collaboration between medical centers and industry with the aim of speeding the delivery of personalized medicine to cancer patients.

The WIN collaborators "bring immense capabilities and expertise that will be invaluable in building our shared capacity to impact the lives of cancer patients around the world through advancing personalized cancer medicine," says John Mendelsohn, M.D., Chairman of the WIN Consortium.

WIN's first and ongoing clinical trial, WINTHER, is open to all patients with solid tumors. WINTHER looks at DNA aberrations/mutations in the tumor but also investigates the transcriptome by looking at the differential RNA expression levels between tumor and normal tissue of the same patient. To date, many targeted therapies are delivered only to those patients showing a mutation in a specific gene. However, some patients may have a normal-looking gene that is being produced at abnormal levels, which is when looking at RNA can be helpful. Using this approach, researchers will be able to match a greater proportion of patients with experimental therapies.

As a WIN member, Jefferson will have the opportunity to suggest novel trials for the consortium's consideration.

The collaboration will also allow Jefferson to offer some of its most exciting approaches such as circulating tumor cell (CTCs) diagnostics, also called liquid biopsy, for tracking the progress of metastatic disease to the international community.

"We can't beat cancer alone. It will take partnerships across institutions, across industries, and across the globe to make sure every patient has the best shot at the right therapy," says Richard Pestell, M.D., Ph.D., Director of the Sidney Kimmel Cancer Center.


'/>"/>

Contact: Edyta Zielinska
edyta.zielinska@jefferson.edu
215-955-5291
Thomas Jefferson University
Source:Eurekalert

Related biology news :

1. University of Strathclyde and NYU join in landmark research and academic partnership
2. An international partnership takes the stage at ESOF 2014
3. Structural Genomics Consortium and CHDI Foundation announce new partnership
4. Full power: Alternative energy partnerships flourish in Asia
5. New international partnership aims to unlock wheats potential
6. Iowa State Universitys Wintersteen talks partnerships at national science meeting
7. MRC funds BREATHE Africa partnership
8. EcoHealth Alliance and Bat Conservation International forge partnership to work on global bat conservation and public health issues
9. Anglo-French partnership develops guidance on future management of English Channel
10. Bold new partnership launches to harness potential of data scientists and big data
11. Wiley and EMBO announce expanded partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/24/2017)... , Mar 24, 2017 Research and Markets ... System Market Analysis & Trends - Industry Forecast to 2025" ... ... grow at a CAGR of around 15.1% over the next decade ... industry report analyzes the market estimates and forecasts for all the ...
Breaking Biology News(10 mins):
(Date:10/10/2017)... 2017 SomaGenics announced the receipt of a ... RealSeq®-SC (Single Cell), expected to be the first commercially ... microRNAs) from single cells using NGS methods. The NIH,s ... accelerate development of approaches to analyze the heterogeneity of ... techniques for measuring levels of mRNAs in individual cells ...
(Date:10/10/2017)... PITTSBURGH, PA (PRWEB) , ... October 10, 2017 ... ... this year’s recipients of 13 prestigious awards honoring scientists who ... be presented in a scheduled symposium during Pittcon 2018, the world’s leading conference ...
(Date:10/9/2017)... FL (PRWEB) , ... October 09, 2017 , ... The ... scheduled to broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on RFD-TV. ... industry is faced with the challenge of how to continue to feed a growing ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... line of medical marijuana products targeting the needs of consumers who are incorporating ... Kindred takes place in Phoenix, Arizona. , As operators of two successful Valley ...
Breaking Biology Technology: